tPA-HP

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NametPA-HP
Drug Alias NameDVT therapy (Elusys)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsVenous Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElusys Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElusys Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A